» Articles » PMID: 34345862

Prediction of Clinical Signs of Respiratory Toxicity in Rats Following Inhalation Exposure

Overview
Specialty Biology
Date 2021 Aug 4
PMID 34345862
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

To date there are no OECD validated alternative approaches to study toxicity following inhalation exposure to airborne chemicals. The available OECD test guidelines for acute inhalation toxicity aim to estimate a value of the lethal air concentration of the test chemical leading to the death of 50% of the exposed animals (LC), to satisfy hazard classification and labelling requirements. This paper explores the view that alternative approaches must compare to outcomes of existing guideline methods to become accepted and implemented in a regulatory context. This case study describes the initiatives taken to validate the lung surfactant bioassay, an cell-free method, and discusses the challenges faced. While the lung surfactant bioassay could not predict the GHS classification for acute inhalation toxicity of 26 chemicals, the assay successfully predicted the clinical signs of respiratory toxicity observed during or shortly after exposure as reported in registration dossiers. The lung surfactant bioassay is a promising alternative approach to assess the potential of chemicals to cause changes to respiration remaining after exposure (indicating decreased lung function), and can be combined with other test methods in an integrated approach to testing and assessment of inhaled substances.

Citing Articles

Evaluation of Machine Learning Based QSAR Models for the Classification of Lung Surfactant Inhibitors.

Liu J, Peeples J, Sayes C Environ Health (Wash). 2024; 2(12):912-917.

PMID: 39722839 PMC: 11667287. DOI: 10.1021/envhealth.4c00118.


Lung surfactant as a biophysical assay for inhalation toxicology.

Liu J, Sayes C Curr Res Toxicol. 2023; 4:100101.

PMID: 36687216 PMC: 9849875. DOI: 10.1016/j.crtox.2022.100101.


An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function.

Da Silva E, Vogel U, Hougaard K, Perez-Gil J, Zuo Y, Sorli J Curr Res Toxicol. 2021; 2:225-236.

PMID: 34345865 PMC: 8320609. DOI: 10.1016/j.crtox.2021.05.005.

References
1.
GOERKE J . Pulmonary surfactant: functions and molecular composition. Biochim Biophys Acta. 1998; 1408(2-3):79-89. DOI: 10.1016/s0925-4439(98)00060-x. View

2.
Wong K, Alarie Y . A method for repeated evaluation of pulmonary performance in unanesthetized, unrestrained guinea pigs and its application to detect effects of sulfuric acid mist inhalation. Toxicol Appl Pharmacol. 1982; 63(1):72-90. DOI: 10.1016/0041-008x(82)90028-x. View

3.
Duch P, Norgaard A, Hansen J, Sorli J, Jacobsen P, Lynggard F . Pulmonary toxicity following exposure to a tile coating product containing alkylsiloxanes. A clinical and toxicological evaluation. Clin Toxicol (Phila). 2014; 52(5):498-505. PMC: 4086232. DOI: 10.3109/15563650.2014.915412. View

4.
Sorli J, Balogh Sivars K, Da Silva E, Hougaard K, Koponen I, Zuo Y . Bile salt enhancers for inhalation: Correlation between in vitro and in vivo lung effects. Int J Pharm. 2018; 550(1-2):114-122. DOI: 10.1016/j.ijpharm.2018.08.031. View

5.
Da Silva E, Vogel U, Hougaard K, Perez-Gil J, Zuo Y, Sorli J . An adverse outcome pathway for lung surfactant function inhibition leading to decreased lung function. Curr Res Toxicol. 2021; 2:225-236. PMC: 8320609. DOI: 10.1016/j.crtox.2021.05.005. View